Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report

Figure 5

Patient 2. Central 30-2 visual field test recorded in March 2016 (a, b) before the start of CBS treatment, June 2016 (c,d) at the end of CBS treatment, and September 2016 (e, f) after four months from the end of CBS treatment, in right (RE) and left (LE) eye.